ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 140 filers reported holding ANIKA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,235 | -51.3% | 163 | -46.2% | 0.00% | – |
| Q1 2023 | $8,702 | -3.0% | 303 | 0.0% | 0.00% | – |
| Q4 2022 | $8,969 | -84.3% | 303 | -87.3% | 0.00% | – |
| Q3 2022 | $57,000 | +338.5% | 2,389 | +315.5% | 0.00% | – |
| Q2 2022 | $13,000 | +160.0% | 575 | +187.5% | 0.00% | – |
| Q1 2022 | $5,000 | -28.6% | 200 | 0.0% | 0.00% | – |
| Q4 2021 | $7,000 | -50.0% | 200 | -34.9% | 0.00% | – |
| Q3 2021 | $14,000 | -79.7% | 307 | -80.6% | 0.00% | – |
| Q2 2021 | $69,000 | +27.8% | 1,585 | +18.7% | 0.00% | – |
| Q1 2021 | $54,000 | +500.0% | 1,335 | +567.5% | 0.00% | – |
| Q4 2020 | $9,000 | -73.5% | 200 | -79.2% | 0.00% | – |
| Q3 2020 | $34,000 | -8.1% | 960 | 0.0% | 0.00% | – |
| Q2 2020 | $37,000 | +32.1% | 960 | 0.0% | 0.00% | – |
| Q1 2020 | $28,000 | -45.1% | 960 | -3.7% | 0.00% | – |
| Q4 2019 | $51,000 | -3.8% | 997 | +3.9% | 0.00% | – |
| Q3 2019 | $53,000 | +23.3% | 960 | -9.4% | 0.00% | – |
| Q2 2019 | $43,000 | +34.4% | 1,060 | 0.0% | 0.00% | – |
| Q1 2019 | $32,000 | -11.1% | 1,060 | 0.0% | 0.00% | – |
| Q4 2018 | $36,000 | -23.4% | 1,060 | -4.8% | 0.00% | – |
| Q3 2018 | $47,000 | +30.6% | 1,114 | +0.5% | 0.00% | – |
| Q2 2018 | $36,000 | -32.1% | 1,108 | +4.5% | 0.00% | – |
| Q1 2018 | $53,000 | -7.0% | 1,060 | 0.0% | 0.00% | – |
| Q4 2017 | $57,000 | -8.1% | 1,060 | 0.0% | 0.00% | – |
| Q3 2017 | $62,000 | +19.2% | 1,060 | 0.0% | 0.00% | – |
| Q2 2017 | $52,000 | +13.0% | 1,060 | 0.0% | 0.00% | – |
| Q1 2017 | $46,000 | +9.5% | 1,060 | +23.3% | 0.00% | – |
| Q4 2016 | $42,000 | -4.5% | 860 | -6.9% | 0.00% | – |
| Q3 2016 | $44,000 | -4.3% | 924 | +7.4% | 0.00% | – |
| Q2 2016 | $46,000 | +12.2% | 860 | -6.5% | 0.00% | – |
| Q1 2016 | $41,000 | +17.1% | 920 | 0.0% | 0.00% | – |
| Q4 2015 | $35,000 | +20.7% | 920 | 0.0% | 0.00% | – |
| Q3 2015 | $29,000 | -52.5% | 920 | -50.5% | 0.00% | – |
| Q2 2015 | $61,000 | +8.9% | 1,859 | +37.8% | 0.00% | – |
| Q1 2015 | $56,000 | -6.7% | 1,349 | -9.1% | 0.00% | – |
| Q4 2014 | $60,000 | +9.1% | 1,484 | 0.0% | 0.00% | – |
| Q3 2014 | $55,000 | +27.9% | 1,484 | +61.3% | 0.00% | – |
| Q2 2014 | $43,000 | – | 920 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caligan Partners LP | 1,081,360 | $20,145,737 | 9.25% |
| Trigran Investments, Inc. | 2,217,019 | $41,303,065 | 4.40% |
| DIKER MANAGEMENT LLC | 50,239 | $935,953 | 0.84% |
| Virtus Investment Advisers, Inc. | 45,579 | $849,137 | 0.58% |
| Virtus Fund Advisers, LLC | 3,490 | $65,019 | 0.46% |
| CAPITAL MANAGEMENT CORP /VA | 84,225 | $1,569,112 | 0.35% |
| Riverwater Partners LLC | 17,597 | $327,832 | 0.30% |
| BOOTHBAY FUND MANAGEMENT, LLC | 617,602 | $11,505,925 | 0.27% |
| XTX Topco Ltd | 28,033 | $522,255 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 51,638 | $962 | 0.08% |